Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain ISRG message board posts where the ticker symbol ISRG has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest ISRG SEC Filings

Filings Format Description Filing Date File/Film Number
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001035267-18-000127 (34 Act)  Size: 7 MB
2018-10-22 000-30713
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001035267-18-000123 (34 Act)  Size: 337 KB
2018-10-18 000-30713
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000121 Size: 13 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000120 Size: 10 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000119 Size: 32 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000118 Size: 8 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000117 Size: 8 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000116 Size: 9 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000115 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001035267-18-000114 Size: 5 KB
More ISRG SEC Filings

Related news from
Mon, 22 Oct 2018
13:50:43 +0000
Edited Transcript of ISRG earnings conference call or presentation 18-Oct-18 8:30pm GMT
Q3 2018 Intuitive Surgical Inc Earnings Call
Mon, 22 Oct 2018
12:03:09 +0000
Intuitive Surgical Reported Strong Third-Quarter Results
Intuitive Surgical (ISRG) released its third-quarter results on October 18. Following strong growth in da Vinci procedures, the company’s total revenues increased from $807.8 million in the third quarter of 2017 to $920.9 million in the third quarter. Most of the growth came from sales of instruments and accessories at $486.3 million in the third quarter—compared to $401.2 million in the third quarter of 2017. Intuitive Surgical’s systems revenues increased from $262.0 million in the third quarter of 2017 to $274.6 million in the third quarter. Intuitive Surgical reported a net income of $292.5 million in the third quarter—compared to a net income of $298.6 million in the third quarter of 2017.
Mon, 22 Oct 2018
11:35:00 +0000
Consolidated Research: 2018 Summary Expectations for Ship Finance International, NexGen Energy, Splunk, Red Hat, Intuitive Surgical, and JinkoSolar Holding Company — Fundamental Analysis, Key Performance Indications
NEW YORK, Oct. 22, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Fri, 19 Oct 2018
14:32:07 +0000
Gauging Analysts’ Views for NovoCure Stock
Of the five analysts covering NovoCure (NVCR) stock in October, two have given it a “strong buy,” and three have given it a “buy.” The mean rating for NovoCure is 1.6 with a target price of $56.50. That implies an upside potential of 24.4% over its trading price of $45.42 on October 18.
Fri, 19 Oct 2018
14:20:03 +0000
Tech Stocks Rebound As Apple Advances On New Bullish Commentary
Tech stocks rebounded Friday amid a number of strong earnings results. Apple jumped on bullish analyst commentary.
Fri, 19 Oct 2018
13:30:00 +0000
Don't Be Fooled -- Intuitive Surgical Had Another Huge Quarter
One time items aren't a concern. This metric shows growth accelerating
Fri, 19 Oct 2018
13:02:26 +0000
NovoCure’s Operational Performance in Q3 2018: What to Expect
NovoCure’s (NVCR) gross income is expected to rise 28.22% to $44.82 million in the third quarter of 2018. Its gross margin is expected to contract from 69.76% in the third quarter of fiscal 2017 to 68.7% in the third quarter of fiscal 2018. NovoCure’s gross margins for fiscal 2018 and fiscal 2019 are expected to be 67.97% and 72.72%, respectively.
Fri, 19 Oct 2018
11:27:02 +0000
Dow Jones Futures Signal Solid Rebound: Five Top Stocks Moving On Earnings
Futures rose early Friday after Thursday's sell-off hit more top stocks. PayPal earnings lifted PayPal and Square. American Express, Atlassian, Intuitive Surgical moved on earnings.
Fri, 19 Oct 2018
09:24:09 +0000
Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues
Strong performance in the Instruments & Accessories and Systems segments drive Intuitive Surgical's (ISRG) top line in Q3.
Fri, 19 Oct 2018
05:17:00 +0000
Intuitive Surgical Inc (ISRG) Q3 2018 Earnings Conference Call Transcript
ISRG earnings call for the period ending September 30, 2018.
Fri, 19 Oct 2018
00:42:03 +0000
Intuitive Surgical Earnings miss, Revenue beats In Q3 - Intuitive Surgical (NASDAQ:ISRG) reported third quarter earnings that missed analyst's expectations on Thursday and revenue that topped forecasts.
Thu, 18 Oct 2018
22:00:07 +0000
Intuitive Surgical Stock Surged on Q3 Earnings Beat
Intuitive Surgical (NASDAQ:ISRG) reported its latest quarterly earnings results late in the day on Thursday, unveiling strong earnings that topped what analysts were calling for in their consensus estimate, which sent its stock surging more than 2% after hours. Intuitive Surgical added that on an adjusted basis when excluding certain items, its profit increased to $2.83 per share for the period. The Wall Street consensus estimate called for Intuitive Surgical to bring in revenue of $916.7 million, per FactSet.
Thu, 18 Oct 2018
20:39:00 +0000
Intuitive Surgical stock rises after hours on earnings beat
Intuitive Surgical Inc. shares rose in the extended session Thursday after the surgical robotics company topped Wall Street estimates for the quarter. Intuitive Surgical shares rose 2.4% after hours, following a 3.8% decline to close the regular session at $522.29. The company reported third-quarter net income of $292.5 million, or $2.45 a share, compared with $298.6 million, or $2.56 a share, in the year-ago period. Adjusted earnings were $2.83 a share. Revenue rose to $920.9 million from $807.8 million in the year-ago period. Analysts surveyed by FactSet had estimated $2.66 a share on revenue of $916.7 million.
Thu, 18 Oct 2018
20:05:00 +0000
Intuitive Surgical Announces Third Quarter Earnings
SUNNYVALE, Calif., Oct. 18, 2018 -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today.
Thu, 18 Oct 2018
18:30:00 +0000
Intuitive Surgical, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / October 18, 2018 / Intuitive Surgical,Inc. (NASDAQ: ISRG) will be discussing their earnings results in their 2018 ThirdQuarter Earnings to be held on October18, 2018 at 4:30:00 ...
Thu, 18 Oct 2018
17:42:05 +0000
Trump vs. The Fed and PayPal, Intuitive Surgical Earnings Previews
Ryan McQueeney discusses the Fed's decision to remain hawkish amid criticism from President Trump. He also recaps earnings results from Travelers, Blackstone, and Philip Morris. Later, he is joined by Dave Bartosiak to preview upcoming reports from PayPal and Intuitive Surgical.
Thu, 18 Oct 2018
17:34:06 +0000
Growth Stocks Smacked Again As Market Correction Intensifies
Growth stocks faced more selling pressure Thursday as the market correction intensified. Activision plunged on Call of Duty sales concerns.
Thu, 18 Oct 2018
15:17:03 +0000
This Week's Hottest Earnings Charts
Wall Street will be tuning into the earnings reports on these 5 companies this week.
Thu, 18 Oct 2018
13:14:00 +0000
Top 5 Things to Know in the Market on Thursday - Here are the top five things you need to know in financial markets on Thursday, October 18:
Thu, 18 Oct 2018
11:56:42 +0000
The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Anixa Biosciences Inc (NASDAQ: ANIX ) Down In The Dumps ...

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This last year I have subscribed to two investment services, ValueForum and a well known income newsletter. ValueForum costs a little over 200 per year. The income newsletter costs about 400 per year. I am up 11% on investments made because I heard about them on ValueForum (of course, I do my own research on everything but the ideas came from ValueForum and there was always some discussion of the pros and cons of each investment on VF). I am down 8% on investments made because I heard about them from the income newsletter. I might also add that I often hear about breaking events immediately on ValueForum and a day or two later the same information is finally available from the newsletter. Hmmm...... which service is the better value?" more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards